Acompanhe as Notícias da Recifes

After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients with follicular lymphoma who received a single infusion of tisagenlecleucel—the CAR T-cell therapy developed by Carl June, MD, that would go on to become t

Telehealth-supported home-based exercise (HBE) achieves comparable short-term improvements to supervised exercise among lymphoma survivors entering cardio-oncology rehabilitation (CORE), according to a study published in Cancer Control.

Primary CNS lymphoma is a rare cancer that arises from malignant white blood cells. Affected individuals develop tumors in the brain and, more rarely, in the spinal cord, the eyes or within the cerebrospinal fluid. These lymphomas can occur in people with weakened immune systems,

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particula

A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma (CTCL) tumors, according to findings published in the Journal of the American Academy of Dermatology.

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical trial evaluated lisocabtagene maraleucel (liso-cel),